PNC Financial Services Group
DNTH icon

PNC Financial Services Group’s Dianthus Therapeutics DNTH Stock Holding History

PNC Financial Services Group’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85M Buy
39,473
+2,113
+6% +$185K ﹤0.01% 827
2026
Q1 		$3.14M Buy
37,360
+139
+0.4% +$8.05K ﹤0.01% 852
2025
Q4 		$1.53M Hold
37,221
– – ﹤0.01% 1077
2025
Q3 		$1.46M Buy
37,221
+121
+0.3% +$3.09K ﹤0.01% 1080
2025
Q2 		$691K Hold
37,100
– – ﹤0.01% 1349
2025
Q1 		$673K Hold
37,100
– – ﹤0.01% 1344
2024
Q4 		$809K Hold
37,100
– – ﹤0.01% 1259
2024
Q3 		$1.02M Hold
37,100
– – ﹤0.01% 1162
2024
Q2 		$960K Hold
37,100
– – ﹤0.01% 1154
2024
Q1 		$1.11M Buy
+37,100
New +$806K ﹤0.01% 1114

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

PNC Financial Services Group's DNTH Position: Q2 2026 in Review

PNC Financial Services Group increased its Dianthus Therapeutics (DNTH) stake by 5.7% in Q2 2026, buying an estimated $185K and bringing the position to 39,473 shares worth $3.85M. The position accounts for ﹤0.01% of the portfolio, ranked #827.

PNC Financial Services Group first reported a position in DNTH in Q1 2024 and has held it in 10 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • PNC Financial Services Group held 39,473 shares of Dianthus Therapeutics worth $3.85M as of Q2 2026.
  • PNC Financial Services Group bought 2,113 Dianthus Therapeutics shares in Q2 2026, an estimated $185K.
  • Dianthus Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #827 holding.
  • PNC Financial Services Group first reported a position in Dianthus Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.